Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Xiexie, Liu"'
Publikováno v:
Human Gene Therapy. 30:673-681
Traditional gene therapy (gene replacement) has made a breakthrough in treating inherited diseases. Adeno-associated virus (AAV) has emerged as a highly promising vector with innate ability, boosting the development of gene replacement and gene targe
Autor:
Xiaoyu Liu, Dingbo Zhang, Feng Gu, Xiexie Liu, Fayu Yang, Yong Liu, Lingkai Gu, Haihua Xie, Qianwen Ren, Caixia Gao, Yufei Wang, Bang Wang, Xiubin He, Tianyuan Zhao
Publikováno v:
Journal of Biological Chemistry. 294:9308-9315
CRISPR/Cas9 nucleases are widely used for genome editing but can induce unwanted off-target mutations. High-fidelity Cas9 variants have been identified; however, they often have reduced activity, constraining their utility, which presents a major cha
Autor:
Zongming Song, Xiexie Liu, Ji-Neng Lv, Xiaoyu Liu, Junzhao Zhao, Haihua Xie, Chenchen Zhou, Yuanyuan Liu, Bang Wang, Xiubin He, Yong Liu, Xiujuan Lv, Mingchun Li, Feng Gu, Lianchao Tang, Changbao Liu
Publikováno v:
The Journal of Biological Chemistry
Clustered regularly interspaced short palindromic repeat–Cas12a has been harnessed to manipulate the human genome; however, low cleavage efficiency and stringent protospacer adjacent motif hinder the use of Cas12a-based therapy and applications. He
Autor:
Xiubin, He, Yufei, Wang, Fayu, Yang, Bang, Wang, Haihua, Xie, Lingkai, Gu, Tianyuan, Zhao, Xiexie, Liu, Dingbo, Zhang, Qianwen, Ren, Xiaoyu, Liu, Yong, Liu, Caixia, Gao, Feng, Gu
Publikováno v:
J Biol Chem
CRISPR/Cas9 nucleases are widely used for genome editing but can induce unwanted off-target mutations. High-fidelity Cas9 variants have been identified; however, they often have reduced activity, constraining their utility, which presents a major cha
Autor:
Zongming Song, Xianglian Ge, Junzhao Zhao, Jia Qu, Junsong Zhang, Fayu Yang, Xiexie Liu, Xiubin He, Chenchen Zhou, Changbao Liu, Feng Gu, Huihui Sun
Publikováno v:
Journal of genetics and genomics = Yi chuan xue bao.
Autor:
Xiexie Liu1, Xiaoyu Liu1, Chenchen Zhou1, Jineng Lv1, Xiubin He1, Yuanyuan Liu1, Haihua Xie1, Bang Wang1, Xiujuan Lv1, Lianchao Tang1, Mingchun Li1, Changbao Liu2, Junzhao Zhao2, Yong Liu1, Zongming Song1,3, Feng Gu1 gufenguw@gmail.com
Publikováno v:
Journal of Biological Chemistry. Jan-Jun2021, Vol. 296, p1-10. 10p.
Autor:
Qianwen Ren, Xiujuan Lv, Jin Li, Junzhao Zhao, Fanfan Li, Feng Gu, Bang Wang, Xiubin He, Yufei Wang, Haihua Xie, Ruzhi Deng, Zongming Song, Xiexie Liu, Congsheng Cheng
Publikováno v:
Biotechnology Journal. 14:1800689
Genome editing using RNA-guided nucleases in their ribonucleoprotein (RNP) form represents a promising strategy for gene modification and therapy because they are free of exogenous DNA integration and have reduced toxicity in vivo and ex vivo. Howeve
Autor:
Junjie Liu, Xiubin He, Xianglian Ge, Jin Li, Junzhao Zhao, Jia Qu, Chenchen Zhou, Haihua Xie, Lianchao Tang, Changbao Liu, Feng Gu, Zongming Song, Xiexie Liu
Publikováno v:
Biotechnology Journal. 13:1800080
CRISPR/Cas9-mediated gene therapy holds great promise for the treatment of human diseases. The protospacer adjacent motif (PAM), the sequence adjacent to the target sequence, is an essential targeting component for the design of CRISPR/Cas9-mediated
Autor:
Xie, Haihua, Tang, Lianchao, He, Xiubin, Liu, Xiexie, Zhou, Chenchen, Liu, Junjie, Ge, Xianglian, Li, Jin, Liu, Changbao, Zhao, Junzhao, Qu, Jia, Gu, Feng, Song, Zongming
Publikováno v:
Biotechnology Journal; Mar2018, Vol. 13 Issue 3, p1-1, 1p
Publikováno v:
Human Gene Therapy; Jun2019, Vol. 30 Issue 6, p673-681, 9p